Published on Thu Nov 21 2013

JAK inhibitors in psoriasis: a promising new treatment modality.

Shawn G Kwatra, Tushar S Dabade, Cheryl J Gustafson, Steven R Feldman
1
3
4
Abstract

Inflammatory cytokines play a crucial role in the pathophysiology of psoriasis. New therapies are targeting Janus kinases (JAKs), enzymes involved with transduction of cytokine receptor signaling.